一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Journal of Drugs in Dermatology >>article
Journal of Drugs in Dermatology

Journal of Drugs in Dermatology

IF: 1.5
Download PDF

Patient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study.

Published:1 March 2023 DOI: 10.36849/JDD.7165 PMID: 36877880
Charles Kircik, Leon Kircik

Abstract

Background: The well-established sequential use of topical calcipotriene and topical betamethasone dipropionate in combination has been shown to provide greater benefit than either monotherapy. A newer topical fixed combination formulation of calcipotriene 0.005% and betamethasone dipropionate 0.064% in a cream base (Cal/BD cream) is effective with high patient ratings for convenience and tolerability. The current study compares patient satisfaction between Cal/BD foam and Cal/BD cream formulations. Study Design and Patient Demographics: This is a single-use, split body, open label study involving 20 subjects. Ten subjects additionally had scalp psoriasis. Study treatments were applied by the investigator in a randomized manner and patients completed questionnaires to assess treatment preferences.

Findings: Both Cal/BD formulations provided rapid and significant improvement in symptoms of pruritus, stinging, burning, and pain; with no statistically significant difference in response between the 2 treatments. Overall, Cal/BD cream outperformed Cal/BD foam on several key measures for vehicle features and patient satisfaction. For non-scalp application, 55% of subjects preferred Cal/BD cream over Cal/BD foam. For the scalp, 60% of subjects preferred Cal/BD cream over Cal/BD foam. No adverse events were reported during the study.

Conclusion: Results of this current study indicate high levels of patient satisfaction with Cal/BD cream and a preference for the cream base over foam for the treatment of body and scalp psoriasis. ? J Drugs Dermatol. 2023;22(3): doi:10.36849/JDD.7165.

Substances (4)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Betamethasone 17,21-dipropionate 5593-20-4 C28H37FO7 429 suppliers $39.00-$1898.00
Calcipotriene 112828-00-9 C27H40O3 177 suppliers $56.00-$1960.00
5 KG YEAST EXTRACT SERVABACTERPOWDER 27 suppliers Inquiry
Container, Foam, Large 7 suppliers Inquiry

Similar articles

IF:2.8

Evaluation of Bioequivalence and Pharmacokinetic Profiles for Topical Desonide Cream Using Chinese Skins.

Skin Pharmacology and Physiology Yuanyuan Sun,?Nan Yang,etc Published: 19 August 2024
IF:12.8

The importance of dual 5α-reductase inhibition in?the?treatment of male pattern hair loss: Results?of?a?randomized placebo-controlled study?of?dutasteride versus finasteride

Journal of the American Academy of Dermatology Elise A. Olsen MD , Maria Hordinsky MD ,etc Published: 1 December 2006
阿克| 长武县| 当雄县| 民权县| 彭阳县| 股票| 建宁县| 大洼县| 石柱| 肥西县| 通山县| 民乐县| 鄂尔多斯市| 徐闻县| 罗平县| 镇康县| 姚安县| 万年县| 吉木萨尔县| 北宁市| 收藏| 深州市| 南部县| 壤塘县| 扬中市| 黔西县| 常宁市| 浏阳市| 黔西县| 海淀区| 固始县| 城步| 额敏县| 天台县| 平罗县| 洪雅县| 开江县| 永济市| 清流县| 安国市| 砀山县|